Platelet-Rich Plasma Market To Reach US$ 780.8 Million By 2027 - Coherent Market Insights

 

Platelets are storage pools of growth factors such as platelet-derived growth factor, transforming growth factor-ß, platelet-derived epidermal growth factor, vascular endothelial growth factor, insulin-like growth factor-1, fibroblastic growth factor and epidermal growth factor. Platelets also contain cytokines and other proteins, which promote wound healing.

Statistics

The global Platelet-Rich Plasma Market is estimated to account for US$ 352.8 Mn in terms of value in 2020 and is expected to reach US$ 780.8 Mn by the end of 2027.

Global Platelet-rich Plasma Market: Drivers

Approval and launch of new products is expected to propel growth of the global platelet-rich plasma market over the forecast period. For instance, in August 2020, Ortho Regenerative Technologies Inc. announced that Ortho-R, a Chitosan-based matrix biopolymer mixed with platelet-rich plasma, is designated as a Drug/Biologic combination product, by the FDA Office for Combination Products.

Global Platelet-rich Plasma Market: Opportunities

R&D in platelet-rich plasma is expected to offer lucrative growth opportunities for players in the global platelet-rich plasma market. For instance, in September 2020, researchers from Victoria University, Australia, reported that leucocyte-rich platelet-rich plasma has a continuous stimulatory anabolic and ergogenic effect on human fibroblast cells.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/936

Global Platelet-rich Plasma Market: Restraints

The reimbursement criteria for the use of platelet-rich plasma therapy in cosmetic surgeries have remained unchanged, as of April 2014. This fact is likely to restrict the use of platelet-rich plasma products for cosmetic surgeries. Such scenario is expected to hinder growth of the global platelet-rich plasma market.

Key Takeaways:

The global platelet-rich plasma market was valued at US$ 314.6 Mn in 2019 and is forecast to reach a value of US$ 780.8 Mn by 2027 at a CAGR of 12.0% between 2020 and 2027. Major factor driving the growth of global platelet rich plasma market during the forecast period include technological advancement, and increasing prevalence of chronic diseases.

Pure PRP held dominant position in the global platelet-rich plasma market in 2019, accounting for 40.9% share in terms of value, followed by Leukocyte rich PRP and Pure PRF, respectively. Increasing use of plasma therapy is expected to support growth of the segment over the forecast period.

Market Trends

Increasing geriatric population is expected to boost growth of the global platelet-rich plasma market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.    

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/platelet-rich-plasma-market-936

Moreover, increasing adoption of platelet-rich plasma is also expected to boost growth of the global Platelet-rich plasma market. For instance, in August 2019, A-to-Zen Regenerative Medicine in Bellevue, Washington, announced expansion of leading menu of skin rejuvenation treatments with state-of-the-art platelet-rich plasma (PRP) Facials and PRP Facelifts for all-natural, age-defying complexion benefits.

Global Platelet-rich Plasma Market: Competitive Landscape  

Major players operating in the global platelet-rich plasma market include, Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd., Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., CollPlant, Generex Biotechnology Corporation, and Estar Technologies Ltd.

Global Platelet-rich Plasma Market: Key Developments

Major players in the global platelet-rich plasma market are focused on adopting M&A strategies to enhance their market share. For instance, in January 2019, Generex Biotechnology Corporation entered into a letter of intent to acquire Medisource Partners, an FDA-registered distributor of medical and surgical products including supplies kits to process bone marrow aspirates and platelet-rich plasma biologics at the time of surgery.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/936

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Intracranial Pressure Monitoring Devices Market Opportunity Analysis - 2026

 

Rising awareness about neurodegenerative diseases is expected to propel the growth of intracranial pressure monitoring devices market

Regional segmentation of Intracranial Pressure Monitoring Devices Market by Coherent Market Insights comprises of North America, Latin America, Europe, Africa, Asia Pacific, and The Middle East. According to Centers for Disease Control and Prevention (CDC) in U.S, there are around 2 to 3 million Traumatic Brain Injury (TBI) cases  registered every year, that eventually lead to the more usage of intracranial pressure monitors in North America. Hence the rising number of patients with such diseases and increase in the usage of intracranial pressure monitoring devices are the factors that leads to domination of North America in intracranial pressure monitoring devices market. Rising government initiatives to generate the awareness about the neurodegenerative disorders also propelling the growth of intracranial pressure monitoring devices market.

Intracranial pressure is the pressure inside the skull that might increase due to rise in pressure of cerebrospinal fluid or it may be due to rise in pressure within the brain. Intracranial pressure might arise due to a brain tumor, fluid around the brain or bleeding into the brain, or swelling within the brain. Increased intracranial pressure can be observed in hepatic encephalopathy, head trauma, hydrocephalus, and cerebral edema. Elevated intracranial pressure can lead to death in neurosurgical patients or it may cause cerebral ischemia. To avoid this circumstance, rapid recognition and monitoring of elevated intracranial pressure is important. Elevated intracranial pressure can be  measured,  either clinically or quantitatively.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/941

Growing population with the neurological disorders globally is certainly driving the intracranial pressure monitoring devices market

A Number of neurological disorders and traumatic accidents are increasing day by day. According to the  United Nations data of 2007, around 1 billion people, that is, 1 in every 6 of the world’s population suffered from neurological disorders, epilepsy, Alzheimer’s, strokes, multiple sclerosis and migraines.. The increasing number of population with neurological disorders is the major factor that is driving the intracranial pressure monitoring devices market. Additionally, According to Centers for Disease Control and Prevention, around 2.5 million cases of traumatic accidents are registered in U.S. that lead to brain infection, meningitis, and aneurysm globally, results in the requirement of intracranial pressure monitoring and hence propels the growth of intracranial pressure monitoring devices. A Large amount of funds have been invested by the government for the improvement of the healthcare sector, expected to boost the intracranial pressure monitoring devices market.

However, the high cost of this monitoring devices and lack of skilled professionals for handling the devices are the factors which  restraints  the growth of intracranial pressure monitoring devices market. Intracranial pressure monitoring devices which are mostly used today are with   certain limitations hence the development and validation of intracranial pressure monitors that would measure absolute intracranial pressure is expected to create the opportunity in intracranial pressure monitoring market.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/intracranial-pressure-monitoring-devices-market-941

External ventricular drainage segment holds the largest share in the intracranial pressure monitoring devices market due to its accurate measurement of intracranial pressure

Mergers & acquisitions are helping the industry players to obtain the maximum share in intracranial pressure monitoring devices market

Key players operating the intracranial pressure monitoring devices market includes  Codman & Shurtleff  Incorporated, Sophysa, Gaeltec Devices Limited, Integra Lifesciences Co., Raumedic AG, VITTAMED, Orsan Medical Technologies, Haiying Medical, and others. The industry players had adopted the strategy of mergers and acquisitions, and partnership to hold the largest share in the intracranial pressure monitoring devices market.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/941

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Immunoassay Instruments Market Size Share Trends Forecast 2026

 

Asia Pacific is expected to lead the market promoting the utilization of immunoassays with the rise in infectious diseases

Regional segmentation of the Immunoassay Instruments Market by Coherent Market Insights comprises North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. North America is expected to dominate the global market owing to the rising demand for technologically advanced clinical diagnostic analyzers capable to perform multiple immunoassays simultaneously. According to the article published in Genetic Engineering and Biotechnology News (GEN), the market for infectious disease testing in the U.S. is expected to grow from U.S. $168 billion in 2015 to U.S. $209 billion in 2020 owing to the upsurge of infectious diseases. Additionally, the rising grants from the government and the private healthcare agencies, contributing towards the development of technology and commercialization of immunoassay analyzers, thereby raising the market in North America. The immunoassay instruments market is expected to boost in Asia Pacific owing to the rising research activities in microbiology sector, increasing the prevalence of infectious and chronic diseases like cholera, tuberculosis, typhoid, autoimmune diseases and rising government healthcare grants. For instance, China directed immunoassay market at an estimated U.S. $626 million in 2013 and is estimated to reach U.S. $1309 million by 2018.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/942

Immunoassay Instruments are bioanalytical devices used to perform automated biochemical tests for the detection of various substances or specific proteins in the samples. The immunoassay instruments, also known as analyzers are used in hospitals and clinical laboratories to detect the concentration and presence of analytes in the blood, plasma and urine samples. The immunoassay tests rely on the ability of antibody binding to a specific structure of molecule present in the analytes. The concentration of proteins is measured using the specific antigen-antibody binding properties. The quantification and identification of proteins in the analyte sample is done by using the antibody as a reagent. The advantages of using immunoassay instruments are the minimal human resistance, simultaneous screening of multiple samples. The high sensitivity, reliability, and applicability to a range of compounds, distinctive selective and detection abilities at extremely low concentrations of nanogram to pictogram make immunoassays a powerful tool.

A wide variety to address health problems drives the immunoassay instruments market

According to the Disease Prevention and Health Promotion estimates in 2017, the immunoassay techniques have prevented up to 14 million lives with early diagnosis, reducing the healthcare costs by $9.9 billion. The adoption of automated techniques to test various substances including antibiotic, anticonvulsant or cardiac glycoside drug concentration determination, cancer markers, endocrine hormone testing drives the market. Rising prevalence of infectious diseases with early diagnosis, prevention, and treatment is the main factor boosting the demand for compact consumable products and instruments in the healthcare sector. The launch of various FDA approved innovative products is expected to fuel the commercialization of immunoassay instruments significantly in the forecast period. For instance, the launch of fluorescence scanning portable instrument ichroma II and enzyme-linked immunosorbant assay (ELISA) test cartridge by iStat cardiac Troponin I.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/immunoassay-instruments-market-942

Improved workflow owing to ease and comprehensive technology are the prominent factors estimated to boost the automated immunoassay instrument market

The launch of automated chemiluminescence immunoassay instrument by Abbott to rise the demand of immunoassay instruments

The key players operating the immunoassay market are Siemens, Roche Diagnostics, Abbott Laboratories, Danaher Corporation, and BioMérieux SA. The innovative measures adopted by the leading manufacturers to perform different assays in a short time with minimal operator intervention leads to the rising demand by the manufacturers. For instance, the launch of automated immunoassay instrument working on the principle of chemiluminescence Architect i1000SR by Abbott offers high precision, good performance, and low detection limits. Other key vendors operating the market are Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, Siemens Medical Solutions Diagnostics, and Trinity Biotech.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/942

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Multiplexed Diagnostic Market Size, Trends, Shares, Insights and Forecast – 2019-2027

 

Global Multiplexed Diagnostic Market, by Product Type (Reagents & Consumables and Instruments), by Application (Disease Diagnostics, Molecular Diagnostics, and Drug Development), by End User (Hospitals, Clinical Laboratories, Academic & Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is expected to be valued at US$ 10,126.6 million in 2019 and is expected to exhibit a CAGR of 7.9% over the forecast period (2019-2027), as highlighted in a new report published by Coherent Market Insights.

The increasing incidence of chronic diseases such as cardiovascular disease (CVD), cancer, diabetes, and respiratory diseases including asthma and chronic obstructive pulmonary disease are expected to drive the multiplexed diagnostic market over the forecast period. For instance, in 2016, the World Health Organization (WHO) estimated around 40.5 million deaths due to non-communicable diseases (NCDs), which include cardiovascular diseases, cancer, diabetes and chronic lung diseases. The leading cause of deaths in 2016 was cardiovascular diseases, whereas 1.6 million people died due to diabetes.

Furthermore, according to the Cancer Research UK, around 20 cases of ovarian cancers are diagnosed every day and it is estimated to increase by around 15% from 2014 to 2035, while American Cancer Society has estimated that in 2020, around 13,130 new cases of soft tissue sarcomas will be diagnosed in the U.S.  Thus, increasing incidence of various cancer is expected to drive demand for precise multiplexed diagnostic tools, which in turn is expected to fuel the market growth.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/983

Browse 54 Market Data Tables and 35 Figures spread through 140 Pages and in-depth TOC on “Multiplexed Diagnostic Market”- Global Forecast to 2027, by Product Type (Reagents & Consumables and Instruments), by Application (Disease Diagnostics, Molecular Diagnostics, and Drug Development), by End User (Hospitals, Clinical Laboratories, Academic & Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa).

Key players in the market are focused on adoption of expansion strategies such as mergers and acquisitions, collaborations, and partnerships, in order to expand their product portfolio and global presence in the multiplexed diagnostic market. For instance, in April 2019, Meridian Bioscience, Inc. entered into an agreement to acquire GenePOC Inc., a Canada-based provider of molecular diagnostic instruments and assays. With the acquisition Meridian Bioscience included state-of-the art revogene molecular diagnostics platform of GenePOC Inc., in its diagnostics portfolio. Through revogene, Meridian Bioscience offers gastrointestinal disease and core respiratory illness diagnostics solutions to its customers.

Key Takeaways of the Global Multiplexed Diagnostic Market:

The global multiplexed diagnostic market is expected to exhibit a CAGR of 9% over the forecast period, owing to rising incidence of chronic diseases and increasing product launches and approvals. For instance, in October 2017, Mercodia AB launched the AKURIO Islet Hormone multiplex assay with the collaboration of Quansys Bioscience.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/multiplexed-diagnostic-market-983

AKURIO is designed to assess four different hormones in pancreatic study, which include glucagon, insulin, C-peptide, and proinsulin. AKURIO Islet Hormone multiplex assay provides high data accuracy with reliable speed.

Among product type, reagents & consumables segment held a significant market share in 2018, owing to increasing product launches and approvals. For instance, in January 2019, Biocare Medical, LLC, launched VALENT IVD (in vitro diagnostic) automated staining platform. VALENT is a fully automated, open platform, and merging high-throughput user interface, which offers 48-slide capacity, multiplex immunohistochemistry (IHC) capability, and high-quality staining.

Among application, disease diagnostics segment held a significant market share in 2018, owing to increasing product launches and approvals. For instance, in December 2019, Co-Diagnostics, Inc. received approval from the Central Drug Standard Control Organization (CDSCO), India, for Saragene. Saragene is designed to carry out five diagnostic test which include Mycobacterium tuberculosis, malaria, hepatitis B, hepatitis C, and human papillomavirus (HPV).

Companies operating in the global multiplexed diagnostic market include Luminex Corporation, Thermo Fisher, Illumine Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Abbott Laboratories, Siemens Healthineers, Agilent technologies, BioMerieux SA, and F.Hoffmann-La Roche Ltd.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/983

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Cloud Computing Market To Reach US$ 40,188.3 Million By 2027 - Coherent Market Insights

 

Cloud computing, often referred to as ‘the cloud’, is a method to store and access the data and programs over the internet. The cloud computing is the delivery of computing resources over the internet on a pay-for-use basis. The resources which are used are elastic and the user pay for the services procured. Cloud computing helps the healthcare industry in numerous ways such as it allows professionals to store and access data remotely, it provides the great reach during the times of disaster so that the professionals can reach to the required places, it provides and holds more information at a lower cost, and clouding helps to share and store data, which helps to speed up the medical research.

The global Cloud Computing Market in healthcare industry is estimated to account for US$ 10,045.0 Mn by 2020 in terms of value and is expected to reach US$ 40,188.3 Mn by the end of 2027.

Global Cloud Computing Market in Healthcare Industry: Drivers

Increasing adoption of cloud computing is expected to propel growth of the global cloud computing market in healthcare industry over the forecast period. For instance, in December 2019, KCR S.A., a healthcare contract research outsourcing company, adopted Veeva Vault, a cloud enterprise content management platform, for its clinical research programs.

Global Cloud Computing Market in Healthcare Industry: Opportunities

Increasing penetration of internet is expected to offer lucrative growth opportunities for players in the global cloud computing market in healthcare industry. For instance, according to China government-backed Market Intelligence & Consulting Institute and reported by China Internet Watch, internet penetration in China reached 61.2 percent in the first half of 2019, with 854 million internet users at the end of June 2019.

Global Cloud Computing Market in Healthcare Industry: Restraints

Low adoption of internet in emerging regions is expected to hinder growth of the global cloud computing market in healthcare industry. For instance, according to Pew Research Center (October 2019), Sub-Saharan Africa has a lower level of internet use than any other geographic region, ranging from a high of 59% in South Africa to a low of 25% in Tanzania. 

Key Takeaways:

The global cloud computing market in healthcare industry was valued at US$ 8,258.1 Mn in 2019 and is forecast to reach a value of US$ 40,188.3 Mn by 2027 at a CAGR of 21.9% between 2020 and 2027. Major factor driving the growth of global cloud computing market in healthcare industry market during the forecast period include technological advancement, and increasing use of mobile applications and connected health.

IaaS held dominant position in the global cloud computing market in healthcare industry in 2019, accounting for 80.8% share in terms of value, followed by PaaS and SaaS, respectively.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/944

Market Trends

Major players in the global cloud computing market in healthcare industry are focused on adopting M&A strategies to enhance their market share. For instance, in April 2018, Topcon Corporation announced that Topcon Healthcare Solutions, a subsidiary in the U.S., acquired all the outstanding shares of KIDE Clinical Systems Oy, a provider of optical and ophthalmology cloud solutions.

Major players in the market are also focused on launching new services to expand their product portfolio. For instance, in April 2018, Oracle Corporation, a multinational computer tech company, launched its Oracle Health Sciences mHealth connector cloud service designed to aid clinical study teams in remotely collecting data from patient sensors, wearable and apps for use in clinical trials.

Global Cloud Computing Market in Healthcare Industry: Competitive Landscape  

Major players operating in the global cloud computing market in healthcare industry include, Carecloud Corporation, Cleardata Networks, Carestream Health, Inc., AGFA Healthcare, Cisco Systems, Inc., Merge Healthcare, Inc., IBM Corporation, Intel Corporation, Microsoft Corporation, Oracle Corporation, Topcon Corporation, AdvancedMD, RxSafe, LLC, Ambra Health, Sectra, and MedShift.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/healthcare-cloud-computing-market-944

Global Cloud Computing Market in Healthcare Industry: Key Developments

Major players in the global cloud computing market in healthcare industry are also focused on adopting partnership strategies to expand their product portfolio. For instance, in March 2020, Sectra signed a contract with Region Halland, a Sweden-based healthcare provider, to deliver its RIS as a cloud service.

Similarly, in February 2020, NANO-X IMAGING LTD partnered with Siemens Healthineers-backed USARAD, under which USARAD will utilize existing radiologists and recruit additional professionals to become service providers using the Nanox.ARC and the Nanox.CLOUD for imaging diagnostics.

Major players in the global cloud computing market in healthcare industry are focused on launching new services to expand their product portfolio. For instance, in March 2020, Phunware, Inc., a fully-integrated enterprise cloud platform, launched a National Ventilator Registry

Similarly, in May 2019, MedShift launched Version 2 of its connected device software, a new secure cloud computing platform designed to enhance manufacturer visibility, and device ROI.

Major players in the global cloud computing market in healthcare industry are focused on adopting M&A strategies to enhance their market share. For instance, in May 2020, Cisco announced its intent to acquire privately held ThousandEyes, Inc., a provider of internet and cloud intelligence platform headquartered in San Francisco, U.S.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/944

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Insomnia therapeutics Market Size, Trends, Shares, Insights and Forecast – 2018-2026

 

Insomnia therapeutics Market By Drug Class (Nonbenzodiazepines, Benzodiazepines and Others) and By Distribution Channel (Retail & Hospital Pharmacies and Online Pharmacies) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

Insomnia is a common type of sleep disorder and frequently co-morbid with mental or psychiatric illness. Consistent risk factors for insomnia are age, and stress associated with job, family, financial, and medical conditions. Increase in consumption of alcohol, caffeine, nicotine could also lead to insomnia. Depending on the duration, insomnia is categorized into transient and chronic insomnia. Transient insomnia last for a single night to few weeks or months and is an adaptive response to the above mentioned challenges. Chronic insomnia is more complex resulting from combination of factors mentioned above and lasts for longer period of time. Insomnia is normally treated with prescription medication or over the counter sleep aid such as natrol melatonin and unisom sleep gel help people to fall asleep with minimum side effects. According to a study by University of Laval, 2011, about 40 % of the adult Canadian are experiencing one or more symptoms of insomnia. Further, a latest research reported in Nature, 2017, stated that insomnia increases the risk in women to deliver premature babies by 30%. Increase in incidence of insomnia across the globe will propel the insomnia therapeutics market.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/958

New improved medication with lesser side effects will drive the insomnia therapeutics market growth globally

Benzodiazepines (BZP) such as temazepam and diazepam are the commonly prescribed medication for insomnia. Though these medications are effective, prolonged use of these drugs may cause cognitive impairment, dependency and addiction. The launch of novel drugs such as Intermezzo (2014), tasimelteon (2014) have created a meteoric growth in G7 countries in the insomnia therapeutics and is expected market over the forecast period.

Intermezzo (2014), are used in small doses and administered under the tongue for faster absorption. Tesimelton approved by FDA in 2014 is the only drug approved by FDA for Non-24-Hour Sleep-Wake Rhythm Disorder and it lacks abuse potential. These products are expected to drive the insomnia therapeutics market over the forecast period.

Increasing awareness and treatment seeking rates for insomnia are expected to further contribute to the growth of the market. However, the loss of exclusivity of the drugs led the market more genericized, creating a competitive environment for new entrants. For instance, non-benzodiazepines and low dose sedating anti-depressants, still considered as a first line of medication for the insomnia, are facing stiff competition from the generics.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/insomnia-therapeutics-market-958

According to a report by Sleep Research Society, 2012, 20% of the general adult population in Canada and U.S is suffering from insomnia and this number is expected to increase in the near future. Problems like daytime sleepiness, and fatigue is affecting larger number of population and imposing a considerable burden on these regions. These factors all together will trigger the total insomnia therapeutics market demand in the future period.  

Devices would have a negative impact on the global insomnia therapeutics market

Rapid entry of new players and new devices for insomnia will boost the market over the forecast period. FDA approved new device Cerêve Sleep System for insomnia in 2016 this device is used to reduce latency to stage 1 and stage 2 sleep by keeping the forehead cool. Major players in insomnia therapeutics market are GlaxoSmithKline plc, UCB Group, Otsuka Holdings Co., Ligand Pharmaceuticals Incorporated, Axxonis Pharma AG, Kyowa Hakko Kirin Co. Ltd., National Institute of Neurological Disorders and Stroke, Jazz Pharmaceuticals, Inc. Ltd., Omeros Corporation and Manhattan Pharmaceuticals, Inc.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/958

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Orthodontic Supplies Market Size, Share, Outlook, and Opportunity Analysis, 2019– 2027

 

Orthodontic Supplies Market - By Product type (Fixed Braces, Removable Braces, and Adhesive), By Brackets Type (Conventional Brackets, Self-ligating Brackets, and Lingual Brackets), By Material (Metal, Ceramic, and Others) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

Orthodontist deals with the diagnosis, prevention, and correction of improper position of teeth and jaws. Comprehensive orthodontic treatment include dental displacement, control, and modification of facial growth with the help of aesthetic ceramic material and stainless steel brackets (braces). Clear aligners are widely used, which are made up of clear plastic. Thus, braces helps in the reconstruction of the entire face rather than focusing on teeth only.

Sports injury and road accidents needs orthodontic treatment services, which fuels the growth of the orthopedics supplies market during the forecast period.

High predominance of dental issues and development of advanced technology which replace surgery is expected to propel the market growth

Regent Dental Care entered into a contract with the Department of Health and Social Care (DHSC) in 2017.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/969

Regent agreed to provide orthodontic treatment services for children under the age of 18 years, which include correction of irregular teeth and jaws and improvement of face and mouth functions. This dental care services is projected to start in DHSC from October 30, 2017, expected to fuel orthodontic supplies market growth.

In 2017, Align Technology announced the first clear aligner system in advance mandibular for class II malocclusion, especially for teen and tween. The clear aligner system provide various benefit to patients such as it reconstruct teeth and jaws, as the product is a simple single-appliance solution and elastic-free correction with six free replacement aligners. This product is also an efficient treatment in terms of cost and time saving, in turn is expected to augment the growth of orthodontic supplies market in the near future.

Major factors hampering the growth of orthodontic supplies market include high cost of orthodontic treatment, limited insurance coverage, and also risk associated with orthodontic treatment. For instance, the Singapore Dental Council (SDC) took strict disciplinary action against a dentist for inaccurate orthodontic treatment in 2017. Thus, such cases may have a negative impact on the growth of orthodontic supplies market in the near future.

Increasing dental and oral health related issues is expected to fuel growth of orthodontic supplies market

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/orthodontic-supplies-market-969

According to the National Health Interview Survey (NHIS), around 47% of women compared to 42% of men and approximately 67% of adults aged over 18 years visited dental health care professionals in early 6 months of 2012. As per NHIS, around 7% of adult population lost their set of natural teeth in 2012. Increasing cases of dental related problem expected to fuel the growth of orthodontic supplies market during the forecast period.

Some of the major key player operating in the global orthodontic supplies market include 3M Company, TP Orthodontics, Inc., Align Technology Inc., Dentaurum GmbH & Co. KG, Danaher Corporation, G&H Orthodontics, Inc., Henry Schein, Inc., Rocky Mountain Orthodontics, Inc., and American Orthodontics.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/969

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Medical Implant Sterile Packaging Market Size Share Trends Forecast 2027

 

Global Medical Implant Sterile Packaging Market, by Product Type (Pouch and Bags, Clamshell, Blister, Tubes, Vials, and Others (Boxes)), by Material Type (Plastic, Paper, Foil, and Glass), by Application (Spinal Implants, Reconstructive Joints (Hip Joints, Knee Joints, Elbow Joints, and Other Small Joints), Extremity Braces and Support (Knee, Elbow, Wrist, Hand, and Foot/Ankle), Dental Implants, Cardiovascular Implants, and Other Implants), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 1,741.3 million in 2019 and is expected to exhibit a CAGR of 7.1%, over the forecast period (2019-2027), as highlighted in a new report published by Coherent Market Insights.

The rising role of contract sterilization service is expected to propel the market growth over the forecast period. Many OEMs are looking for contract manufacturers that offer in house sterilization service, so that the organization can focus on cutting down the overall production and develop new innovative medical implants, as these contract service providers are one-stop-shop for the manufacturers. Therefore, rising demand for sterilization service is expected to propel the market growth over the forecast period.

Development of the innovative technologies for medical implant sterile packaging is expected to propel the market growth.

Introduction of newer and complex medical implants with different testing and packaging solution is driving manufacturers to introduce innovative packaging technique and to focus towards improving the packaging of these complex devices, which is expected to drive growth to the market over the forecast period. For instance, Nelson is engaged in developing several alternative approaches for complex medical combo products.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/995

Various companies are focusing on mitigating risk to the supply chain pipeline and many OEMs are planning for all aspects of production such as sterilization and packaging. Hence this is expected to foster the market growth. Moreover, shifting material preference by the manufacturers in the Middle East and Africa is further expected to augment the market growth.

Browse 35 Market Data Tables and 38 Figures spread through 167 Pages and in-depth TOC on " Global Medical Implant Sterile Packaging Market, by Product Type (Pouch and Bags, Clamshell, Blister, Tubes, Vials, and Others (Boxes)), by Material Type (Plastic, Paper, Foil, Glass), by Application (Spinal Implants, Reconstructive Joints (Hip Joints, Knee Joints, Elbow Joints, Other Small Joints), Extremity Braces and Support (Knee, Elbow, Wrist, Hand, and Foot / Ankle) Dental Implants, Cardiovascular Implants, and Other Implants), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), – Global Forecast to 2027"

The increasing adoption of the inorganic growth strategies such as acquisitions and collaborations by market players are expected to drive growth of the global medical implant sterile packaging market, over the forecast period. For instance, in April 2016, Bemis Company Inc. acquired packaging operation of Steripack Group, a global manufacturer of sterile packaging for medical device and pharmaceuticals. Similarly, in August 2019, Kohlberg closes on Bemis Healthcare Packaging Europe acquisition, and merges with Nelipak, a developer and manufacturers of custom designed thermoformed packaging for the medical device and pharmaceutical

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/medical-implants-sterile-packaging-market-995

Key Takeaways of the Global Medical Implant Sterile Packaging Market:

Global medical implant sterile packaging market is expected to exhibit a CAGR of 7.1% over the forecast period (2019-2027), owing to increasing product launches by key players in the medical implant sterile packaging market. For instance, in July 2017, ECA Medical Instruments launched sterile-packed instrument set to protect cannulated titanium screw. Along with this, company also launched sterile pack kits and instruments for hand and wrist repair, joint arthroplasty, and spine implants.

Among application, dental implant is one of the major segment and is expected to witness significant growth, owing to increasing number of dental implantation procedures. For instance, according to statistics by the American Academy of Implant Dentistry in August 2018, around 3 million people in the U.S. received dental implants. Moreover, around 500,000 people undergo dental implantation treatment each year in the U.S.

Some of the major players operating in the global medical implant sterile packaging market include Oliver Tolas, Bemis Company, Inc, Steripack Contract Manufacturing, Orchid Orthopedic Solutions LLC, Multivac Group., Janco Inc, and Sealed Air Corporation

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/995

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Human Chorionic Gonadotropin (HCG) Market Opportunity Analysis - 2026

 

On the basis of geography, the global Human Chorionic Gonadotropin Market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is the highest regional contributor to the market and is expected to continue as a regional dominator over the forecast years. This primarily owes to the rising number of infertility cases as well as hormonal dysfunction among young males and females as a result of changing lifestyle. According to Mayo Clinic, around 25% of women fertility problems in the U.S. are a result of ovulation issues that are mostly caused due to dysfunction of human chorionic gonadotropin (HCG) hormone. Thus, the rapidly increasing cases of infertility are expected to surge the North America global human chorionic gonadotropin market. On the other hand, Asia Pacific is anticipated to be the fasting growing geography, owing to economic developments facilitating technological advancements in healthcare sectors as well as emerging local players in the market.

Human chorionic gonadotropin hormone (HCG) is a hormone secreted by the placenta after implantation of a fertilized zygote in the uterus. The hormone also supports normal development of an egg and helps in the stimulation of egg release from the ovary. The HCG is mainly used to induce ovulation in the women under infertility treatment. It is also used among males mostly to increase the sperm count and in young boys, due to pituitary gland disorders and other diseases, due to which the testicles of the young males does not drop down naturally into the scrotum. The HCG is usually administered as an injection under the skin into a muscle. The HCG can also be administered at home under the advice of a gynecologist or a pharmacist.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1011

The HCG levels can be determined with the help of urine or blood test. Result of specific test helps in the determining accurate measurement of the levels. These tests are mostly used to identify and confirm pregnancy or as a screening test to determine birth defects.

Rising incidence of infertility are expected to drive the growth of human chorionic gonadotropin market across the globe

According to Centers of Disease Control and Prevention (CDC) in 2016, approximately 7.3 million women aged 15 - 44 have used infertility services. Moreover, 6.7% of the married women aged 15 - 44 were reported infertile. According to Azura Vascular Care, around 17% of the couples in the U.S. deal with infertility out of which 30% cases are a result of male infertility. These numbers suggests significant demand for infertility treatments, such as HCG in order for females to conceive a child. According to a statistical survey conducted by HealthGrove, pituitary gland disorders resulted into the death of around 205 people in 2015, out of which highest percentage belonged to white men. Pituitary disorders resulting into significant mortality rate are propelling the demand for human chorionic gonadotropin hormone. Additionally, various other factors such as endometriosis, hormonal imbalance, polycystic ovary syndrome, and others are expected to propel the growth of global HCG market.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/human-chorionic-gonadotropin-market-1011

For instance, according to Frisco Institute of Reproductive Medicine, around 10% of women of reproductive age in the U.S. suffer from polycystic ovary syndrome. However, easy availability of alternatives to treat infertility could act as potential barriers for the market growth.

North America to dominate global human chorionic gonadotropin (HCG) market, owing to rising frequency of infertility cases

The key players operating the global human chorionic gonadotropin market include Merck & Co., Inc., EMD Sereno, Inc., Fresenius Kabi, Bristol Myers Squibb Company, Ferring BV, and Kamia Biomedical Company. Acris Antibodies developed a human chorionic gonadotropin hormone by recombinant DNA technology that helps to prevent the disintegration of the corpus luteum of the ovary thereby, maintaining levels of progesterone production for healthy pregnancy in females.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1011

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Opioids Market To Surpass US$ 51,005.8 Million By 2027 - Coherent Market Insights

 

Opioid is a type of narcotic pain medication, which is used to treat moderate to severe pain, such as, anesthesia, cough suppression, diarrhea suppression, surgical pain, injury or trauma, cancer pain and pain arising from disease. The global Opioids Market is estimated to account for US$ 51,005.8 Mn in terms of value by the end of 2027.

Global Opioids Market: Drivers

High efficacy of synthetic opioids such as methadone and fentanyl is expected to boost growth of the global opioids market. These synthetically manufactured opioids are used to suppress the chances of getting addicted to natural opioids and resistant to natural opioids.

Global Opioids Market: Opportunities

Increasing R&D in synthesis of hybrids targeting opioid and neurokinin receptors is expected to offer lucrative growth opportunities for market players. For instance, in December 2019, researchers from Medical University of Lodz reported the synthesis, structure–activity relationship, and pharmacological characterization of a series of hybrids combining opioid pharmacophores with either substance P (SP) fragments or neurokinin receptor (NK1) antagonist fragments in order to comprehend the role of the neurokinin system in opioid-induced antinociception.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1017

Global Opioids Market: Restraints

However, increasing cases of counterfeit opioids is expected to hamper growth of the global opioids market. For instance, in June 2019, Drug Enforcement Administration warned regarding sell of counterfeit fentanyl pills and other synthetic opioids.

Key Takeaways:

The Morphine segment in the global opioids market was valued at US$ 13,697.6 Mn in 2018 and is expected to reach US$ 17,766.2 Mn by 2027 at a CAGR of 2.9% during the forecast period. The growth of the segment is attributed to increasing demand for treatment of acute and chronic pain during the forecast period. The Analgesia segment held dominant position in the global opioids market in 2018, accounting for 67.3% share in terms of volume, followed by cough suppression and diarrhoea suppression, respectively. The growth of the segment is attributed to increasing research and development of new drug.

Market Trends

Key players in the market are focused on product approval and launch to expand their product portfolio. For instance, in June 2018, AcelRx Pharmaceuticals, Inc. received the European Commission (EC) approval for DZUVEO for the management of acute moderate to severe pain in adults in medically monitored settings. The market is witnessing increasing M&A activities. For instance, Grünenthal acquired the US-based pharmaceutical company Averitas Pharma in order to expand its presence in the U.S.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/opioid-drugs-market-1017

Regulations

The European Society for Medical Oncology (ESMO) and the European Association for Palliative Care (EAPC) regulates the commercial use of opioids in cancer pain management across Europe

European Union conducts Access to Opioids Medication in Europe (ATOME) program, which ensures the availability of opioids across 12 European countries

The U.K.’s Department of Health published "Drug Misuse and Dependence – Guidelines on Clinical Management" (DOH, 1999), which regulates the prescription and sales of opioid drugs in the country

Global Opioids Market: Competitive Landscape

Major players operating in the global opioids market include Pfizer, Inc., Boehringer Ingelheim, Janssen Pharmaceuticals, Inc., Actavis Plc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals Inc., and Zyla Life Sciences.

Global Opioids Market: Key Developments

In October 2019, AmerisourceBergen, Cardinal Health, McKesson Corporation, Johnson & Johnson, and Teva Pharmaceuticals agreed to pay US$ 50 billion in cash and addiction treatments to resolve opioid cases in U.S. states. In March 2019, Purdue Pharma reached a US$ 270 million settlement in a lawsuit, which claimed its opioids contributed to the deaths of thousands of people.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1017

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737